Related Experiment Video
Updated: Aug 13, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Surgical treatment for stage IV lung cancer]
T Miyazaki1, T Tagawa, A Nakamura
1Division of Surgical Oncology, Nagasaki University Graduate School of Medicine, Nagasaki, Japan.
Objective:
To find out the optimal surgical indication in stage IV lung cancer patients, we evaluated them retrospectively.
Methods & Results:
From 1975 to 2005, 62 patients without multiple metastases were operated at our hospital. The most common histological type was adenocarcinoma (67.7%). The metastatic lesions were lung (33.9%), brain (24.2%), liver, bone, adrenal gland and so on. The overall survival rate of stage IV lung cancer was 10.4% at 5-year. Five-year survival for patients with lung or brain metastasis who had no lymph node metastasis were significantly more superior than those with lymph node metastasis (p=0.0389, 0.0021). Four of 62 patients had 5-year survival. Two were lung and the others were brain and adrenal gland metastasis without lymph node metastasis.
Conclusion:
Stage IV lung cancer with lung or brain or adrenal gland metastasis without lymph node metastasis should be resected.
